We confirmed the presence of multiple genetic variants associated with COVID-19 risk shared across different populations, identified a population-specific risk variant at DOCK2, particularly in young patients with severe COVID-19 collected during the early waves of the pandemic. This evidence concerns the gene DOCK2 and COVID-19.